Acutus Medical

AFIB · OTC

$0.0001+$0.00 (+0.00%)TodayMarket closed ·
Prev close $0.0001

About AFIB

Acutus Medical, Inc. is an arrhythmia management company, which engages in improving the way cardiac arrhythmias are diagnosed and treated. The company is headquartered in Carlsbad, California and currently employs 85 full-time employees. The company went IPO on 2020-08-06. The firm is solely focused on supporting the manufacturing and distribution of products to Medtronic. The company manufactures transseptal crossing devices and associated accessories, such as integrated transseptal dilators and needles, fixed-curve or steerable introducers, and steerable sheaths (i.e., the Products). These Products are used to access the left side, or left atrium, of the cardiac anatomy and are used in a range of medical applications, including in electrophysiology and structural heart procedures. The technology supports physicians during a critical component of an ablation or structural heart procedure. The transseptal crossing devices that it manufactures for Medtronic versions that are length-, diameter- and tip-matched and designed to lock into the hub of sheaths used in many left-heart procedures.

Employees
85
Headquarters
Carlsbad, California
Listed
Aug 6, 2020
Sector
Health Care
Industry
Health Care Equipment & Supplies

Leadership

Acutus Medical executives
NameTitle
Shaden Marzouk—
David Bonita—
Andrew Elbardissi—
Jason Garland—
Niamh Pellegrini—
John Sheridan—

Revenue by product and region

Fiscal year ended Dec 31, 2023: $7.16M total revenue

By product

  • Disposables$6.32M88.1%
  • Service/Other$849.00K11.9%

Suppliers and customers

Price correlation is over one year: 1 means the stocks move together, -1 opposite

Acutus Medical suppliers and customers
CompanyRelationshipCorrelation
BIOTRONIK SE & Co. KGSupplier and customer—

Similar companies

Companies in the same industry as Acutus Medical

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.